NOV 29, 2021 3:00 AM PST

An Amino Acid Can Improve Radiation Therapy for Metastatic Brain Cancer

WRITTEN BY: Katie Kokolus

There are 20 different amino acids that the human body uses to generate proteins.  Amino acids form chains called polypeptides which combine to form specific proteins required for biological functions.  Our genes contain the codes for the amino acid sequences which make up each protein.  

There are two types of amino acids: essential and non-essential.  While essential amino acids cannot be made by the body and must be consumed through the diet, the body produces non-essential amino acids. 

Arginine is one of the amino acids that the body makes on its own. It can also be consumed in high protein foods such as fish, read mead, poultry, whole grains, and dairy. The body converts arginine into a chemical called nitric oxide, which prompts blood vessels to widen or dilate. Doctors can prescribe arginine for some medical issues, including heart disease, because of its ability to work as a vasodilator. Supplemental arginine, commonly referred to as L-arginine, can be administered orally or even intravenously.  

A recent study published in Science Advances suggests a possible new indication for oral arginine in treating metastatic brain cancer.  Patients with metastatic brain cancer, a difficult to treat malignancy characterized by tumor cells spreading to the brain from a distant primary site.  Some brain metastases are inoperable, leading to the use of radiation therapy.  While radiation is effective in some cases, many tumors develop resistance, prompting the need to develop novel therapeutic options. 

Patients with metastatic brain cancer were randomized to treatment with either placebo (32 patients) or arginine treatment (31 patients) followed by whole-brain irradiation.  Participants in the treatment group received 10 grams of arginine one hour before each dose of radiation. 

The study demonstrated that pretreatment with arginine enhanced the efficacy of radiation therapy in patients with brain metastasis.  Only 3% of the participants receiving arginine experienced progressive disease.  Comparatively, 16% of those in the placebo group experienced disease progression.  Close to 80% of the arginine-treated group had a complete or partial response versus only 22% in the placebo group. 

Arginine is an affordable supplement associated with very few toxicities.  Thus, the promising results of this trial suggest that arginine could serve as a safe and inexpensive way to enhance the therapeutic benefit of radiation therapy.    

 

Sources: amino acids, polypeptides, Arginine, vasodilator, Science Advances

About the Author
  • PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 28, 2021
Immunology
Cell Therapy Scrubs Tumors, Spares Transplanted Organs
SEP 28, 2021
Cell Therapy Scrubs Tumors, Spares Transplanted Organs
Hepatitis B infections have created a ‘silent epidemic’—infected people don’t display any sympto ...
NOV 11, 2021
Clinical & Molecular DX
Cancer Pathologist Burnout? AI to the Rescue.
NOV 11, 2021
Cancer Pathologist Burnout? AI to the Rescue.
Diagnosing cancer is hard work. The challenging demands of their caseloads see diagnostic pathologists in many clinical ...
DEC 23, 2021
Cancer
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
DEC 23, 2021
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
It is estimated that nearly 84,000 people will be diagnosed with bladder cancer in the United States this year ...
JAN 06, 2022
Immunology
Gene for Smelling Helps Cancer Cells Move to the Brain
JAN 06, 2022
Gene for Smelling Helps Cancer Cells Move to the Brain
From tasting a delicious meal to picking up pheromones, olfaction (or the sense of smell) involves a network of complex ...
Loading Comments...